Cecha
Behavioral abnormality
Nazwa kliniczna: Atypical behavior
Atypical behavior is an abnormality in a person's actions that can be controlled or modulated by the will of the individual. While abnormal behaviors can be difficult to control, they are distinct from other abnormal actions that cannot be affected by the individual's will.
Podsumowanie
- Znana także jako
- Behavioral changes, Behavioral disorders, Behavioral disturbances, Behavioral problems, Behavioral/psychiatric abnormalities, Behavioural/Psychiatric abnormality, Psychiatric disorders, Psychiatric disturbances, Behavioral symptoms, Behavioural abnormality, Behavioural changes, Behavioural disorders, Behavioural disturbances, Behavioural problems, Behavioural symptoms
- Układ organizmu
- Abnormality of the nervous system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Behavioral abnormality, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test485 genów powiązanych z Behavioral abnormality
Zmiany w tych genach powodują rzadkie choroby, w których występuje Behavioral abnormality. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| GRIN2Bglutamate ionotropic receptor NMDA type subunit 2B | Zawsze | W 1 chorobie |
| LRRC7leucine rich repeat containing 7 | Zawsze | W 1 chorobie |
| ADA2adenosine deaminase 2 | Bardzo często (80–99%) | W 1 chorobie |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Bardzo często (80–99%) | W 1 chorobie |
| APPamyloid beta precursor protein | Bardzo często (80–99%) | W 4 chorobach |
| ARG1arginase 1 | Bardzo często (80–99%) | W 1 chorobie |
| ATRXATRX chromatin remodeler | Bardzo często (80–99%) | W 2 chorobach |
| CASRcalcium sensing receptor | Bardzo często (80–99%) | W 1 chorobie |
| CHMP2Bcharged multivesicular body protein 2B | Bardzo często (80–99%) | W 3 chorobach |
| CPT1Acarnitine palmitoyltransferase 1A | Bardzo często (80–99%) | W 1 chorobie |
| DCXdoublecortin | Bardzo często (80–99%) | W 1 chorobie |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Bardzo często (80–99%) | W 1 chorobie |
| GNA11G protein subunit alpha 11 | Bardzo często (80–99%) | W 1 chorobie |
| GRNgranulin precursor | Bardzo często (80–99%) | W 2 chorobach |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Bardzo często (80–99%) | W 1 chorobie |
| HSD17B10hydroxysteroid 17-beta dehydrogenase 10 | Bardzo często (80–99%) | W 1 chorobie |
| IFNGinterferon gamma | Bardzo często (80–99%) | W 1 chorobie |
| IGF1insulin like growth factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| MAOAmonoamine oxidase A | Bardzo często (80–99%) | W 1 chorobie |
| MAPTmicrotubule associated protein tau | Bardzo często (80–99%) | W 2 chorobach |
| MCOLN1mucolipin TRP cation channel 1 | Bardzo często (80–99%) | W 1 chorobie |
| MED12mediator complex subunit 12 | Bardzo często (80–99%) | W 1 chorobie |
| MMADHCmetabolism of cobalamin associated D | Bardzo często (80–99%) | W 1 chorobie |
| MTHFRmethylenetetrahydrofolate reductase | Bardzo często (80–99%) | W 2 chorobach |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Bardzo często (80–99%) | W 1 chorobie |
| PRNPprion protein (Kanno blood group) | Bardzo często (80–99%) | W 2 chorobach |
| PSEN1presenilin 1 | Bardzo często (80–99%) | W 2 chorobach |
| SH2B1SH2B adaptor protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Bardzo często (80–99%) | W 1 chorobie |
| SQSTM1sequestosome 1 | Bardzo często (80–99%) | W 3 chorobach |
| SUCLA2succinate-CoA ligase ADP-forming subunit beta | Bardzo często (80–99%) | W 1 chorobie |
| TBR1T-box brain transcription factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| TMEM106Btransmembrane protein 106B | Bardzo często (80–99%) | W 2 chorobach |
| TREM2triggering receptor expressed on myeloid cells 2 | Bardzo często (80–99%) | W 4 chorobach |
| TSC1TSC complex subunit 1 | Bardzo często (80–99%) | W 1 chorobie |
| TSC2TSC complex subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| TYROBPtransmembrane immune signaling adaptor TYROBP | Bardzo często (80–99%) | W 1 chorobie |
| UBTFupstream binding transcription factor | Bardzo często (80–99%) | W 1 chorobie |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Bardzo często (80–99%) | W 1 chorobie |
| VCPvalosin containing protein | Bardzo często (80–99%) | W 5 chorobach |
Pokaż jeszcze 445 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| WACWW domain containing adaptor with coiled-coil | Bardzo często (80–99%) | W 3 chorobach |
| ZDHHC9zDHHC palmitoyltransferase 9 | Bardzo często (80–99%) | W 2 chorobach |
| AASSaminoadipate-semialdehyde synthase | Często (30–79%) | W 1 chorobie |
| ABCD1ATP binding cassette subfamily D member 1 | Często (30–79%) | W 3 chorobach |
| AHCYadenosylhomocysteinase | Często (30–79%) | W 1 chorobie |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Często (30–79%) | W 2 chorobach |
| ANGangiogenin | Często (30–79%) | W 1 chorobie |
| ANXA11annexin A11 | Często (30–79%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Często (30–79%) | W 1 chorobie |
| AQP4aquaporin 4 | Często (30–79%) | W 1 chorobie |
| ARID1AAT-rich interaction domain 1A | Często (30–79%) | W 1 chorobie |
| ARID1BAT-rich interaction domain 1B | Często (30–79%) | W 1 chorobie |
| ARID2AT-rich interaction domain 2 | Często (30–79%) | W 2 chorobach |
| ARL6ARF like GTPase 6 | Często (30–79%) | W 1 chorobie |
| ASAH1N-acylsphingosine amidohydrolase 1 | Często (30–79%) | W 2 chorobach |
| ATMATM serine/threonine kinase | Często (30–79%) | W 1 chorobie |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Często (30–79%) | W 2 chorobach |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Często (30–79%) | W 2 chorobach |
| ATP7AATPase copper transporting alpha | Często (30–79%) | W 1 chorobie |
| ATXN2ataxin 2 | Często (30–79%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Często (30–79%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Często (30–79%) | W 1 chorobie |
| BBS10Bardet-Biedl syndrome 10 | Często (30–79%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Często (30–79%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Często (30–79%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Często (30–79%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Często (30–79%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Często (30–79%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Często (30–79%) | W 1 chorobie |
| BICRABRD4 interacting chromatin remodeling complex associated protein | Często (30–79%) | W 1 chorobie |
| BMPR1Abone morphogenetic protein receptor type 1A | Często (30–79%) | W 1 chorobie |
| BPTFbromodomain PHD finger transcription factor | Często (30–79%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Często (30–79%) | W 3 chorobach |
| BRCA2BRCA2 DNA repair associated | Często (30–79%) | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Często (30–79%) | W 4 chorobach |
| CASZ1castor zinc finger 1 | Często (30–79%) | W 1 chorobie |
| CC2D2Acoiled-coil and C2 domain containing 2A | Często (30–79%) | W 1 chorobie |
| CCNFcyclin F | Często (30–79%) | W 2 chorobach |
| CDH23cadherin related 23 | Często (30–79%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Często (30–79%) | W 4 chorobach |
| CEP19centrosomal protein 19 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 2 chorobach |
| CFAP410cilia and flagella associated protein 410 | Często (30–79%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Często (30–79%) | W 1 chorobie |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Często (30–79%) | W 2 chorobach |
| CHD2chromodomain helicase DNA binding protein 2 | Często (30–79%) | W 1 chorobie |
| CHEK2checkpoint kinase 2 | Często (30–79%) | W 1 chorobie |
| CHRNA7cholinergic receptor nicotinic alpha 7 subunit | Często (30–79%) | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Często (30–79%) | W 2 chorobach |
| COL1A1collagen type I alpha 1 chain | Często (30–79%) | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Często (30–79%) | W 2 chorobach |
| CRIPTOcripto, EGF-CFC family member | Często (30–79%) | W 4 chorobach |
| CTCFCCCTC-binding factor | Często (30–79%) | W 1 chorobie |
| CTNNB1catenin beta 1 | Często (30–79%) | W 2 chorobach |
| CUX2cut like homeobox 2 | Często (30–79%) | W 1 chorobie |
| CYP27A1cytochrome P450 family 27 subfamily A member 1 | Często (30–79%) | W 1 chorobie |
| DAOD-amino acid oxidase | Często (30–79%) | W 1 chorobie |
| DCTN1dynactin subunit 1 | Często (30–79%) | W 1 chorobie |
| DDCdopa decarboxylase | Często (30–79%) | W 1 chorobie |
| DISP1dispatched RND transporter family member 1 | Często (30–79%) | W 4 chorobach |
| DLATdihydrolipoamide S-acetyltransferase | Często (30–79%) | W 1 chorobie |
| DLL1delta like canonical Notch ligand 1 | Często (30–79%) | W 4 chorobach |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Często (30–79%) | W 1 chorobie |
| DNM1dynamin 1 | Często (30–79%) | W 2 chorobach |
| DNMT3ADNA methyltransferase 3 alpha | Często (30–79%) | W 1 chorobie |
| DPF2double PHD fingers 2 | Często (30–79%) | W 1 chorobie |
| DPYDdihydropyrimidine dehydrogenase | Często (30–79%) | W 1 chorobie |
| EBF3EBF transcription factor 3 | Często (30–79%) | W 1 chorobie |
| EFL1elongation factor like GTPase 1 | Często (30–79%) | W 1 chorobie |
| EHMT1euchromatic histone lysine methyltransferase 1 | Często (30–79%) | W 2 chorobach |
| ELNelastin | Często (30–79%) | W 1 chorobie |
| ELP1elongator acetyltransferase complex subunit 1 | Często (30–79%) | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Często (30–79%) | W 1 chorobie |
| EPB41L1erythrocyte membrane protein band 4.1 like 1 | Często (30–79%) | W 1 chorobie |
| EPCAMepithelial cell adhesion molecule | Często (30–79%) | W 1 chorobie |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FGF8fibroblast growth factor 8 | Często (30–79%) | W 4 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Często (30–79%) | W 3 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Często (30–79%) | W 2 chorobach |
| FOXH1forkhead box H1 | Często (30–79%) | W 4 chorobach |
| FOXP1forkhead box P1 | Często (30–79%) | W 1 chorobie |
| FRA16Efragile site, distamycin A type, rare, fra(16)(p12.1) | Często (30–79%) | W 1 chorobie |
| FUSFUS RNA binding protein | Często (30–79%) | W 3 chorobach |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Często (30–79%) | W 1 chorobie |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Często (30–79%) | W 1 chorobie |
| GALCgalactosylceramidase | Często (30–79%) | W 1 chorobie |
| GAMTguanidinoacetate N-methyltransferase | Często (30–79%) | W 1 chorobie |
| GAS1growth arrest specific 1 | Często (30–79%) | W 4 chorobach |
| GATA4GATA binding protein 4 | Często (30–79%) | W 1 chorobie |
| GBE11,4-alpha-glucan branching enzyme 1 | Często (30–79%) | W 1 chorobie |
| GLAgalactosidase alpha | Często (30–79%) | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Często (30–79%) | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| GLT8D1glycosyltransferase 8 domain containing 1 | Często (30–79%) | W 1 chorobie |
| GNAQG protein subunit alpha q | Często (30–79%) | W 1 chorobie |
| GNB1G protein subunit beta 1 | Często (30–79%) | W 1 chorobie |
| GPRC5BG protein-coupled receptor class C group 5 member B | Często (30–79%) | W 1 chorobie |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Często (30–79%) | W 1 chorobie |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Często (30–79%) | W 1 chorobie |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Często (30–79%) | W 2 chorobach |
| HDAC4histone deacetylase 4 | Często (30–79%) | W 1 chorobie |
| HEPACAMhepatic and glial cell adhesion molecule | Często (30–79%) | W 1 chorobie |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Często (30–79%) | W 1 chorobie |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Często (30–79%) | W 1 chorobie |
| HSPG2heparan sulfate proteoglycan 2 | Często (30–79%) | W 1 chorobie |
| HTRA1HtrA serine peptidase 1 | Często (30–79%) | W 1 chorobie |
| HTThuntingtin | Często (30–79%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Często (30–79%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Często (30–79%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Często (30–79%) | W 1 chorobie |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Często (30–79%) | W 1 chorobie |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Często (30–79%) | W 1 chorobie |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Często (30–79%) | W 2 chorobach |
| KIF15kinesin family member 15 | Często (30–79%) | W 1 chorobie |
| KLF13KLF transcription factor 13 | Często (30–79%) | W 1 chorobie |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 1 chorobie |
| KMT2Clysine methyltransferase 2C | Często (30–79%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 2 chorobach |
| KYkyphoscoliosis peptidase | Często (30–79%) | W 1 chorobie |
| L2HGDHL-2-hydroxyglutarate dehydrogenase | Często (30–79%) | W 1 chorobie |
| LMX1BLIM homeobox transcription factor 1 beta | Często (30–79%) | W 1 chorobie |
| LRP12LDL receptor related protein 12 | Często (30–79%) | W 1 chorobie |
| LUZP1leucine zipper protein 1 | Często (30–79%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Często (30–79%) | W 1 chorobie |
| MAGEL2MAGE family member L2 | Często (30–79%) | W 6 chorobach |
| MAPK10mitogen-activated protein kinase 10 | Często (30–79%) | W 1 chorobie |
| MATR3matrin 3 | Często (30–79%) | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Często (30–79%) | W 1 chorobie |
| MEN1menin 1 | Często (30–79%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Często (30–79%) | W 1 chorobie |
| MKRN3makorin ring finger protein 3 | Często (30–79%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 1 chorobie |
| MLC1modulator of VRAC current 1 | Często (30–79%) | W 1 chorobie |
| MLH1mutL homolog 1 | Często (30–79%) | W 1 chorobie |
| MLXIPLMLX interacting protein like | Często (30–79%) | W 1 chorobie |
| MMP23Bmatrix metallopeptidase 23B | Często (30–79%) | W 1 chorobie |
| MSH2mutS homolog 2 | Często (30–79%) | W 1 chorobie |
| MSH6mutS homolog 6 | Często (30–79%) | W 1 chorobie |
| MSL3MSL complex subunit 3 | Często (30–79%) | W 1 chorobie |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Często (30–79%) | W 1 chorobie |
| MUTYHmutY DNA glycosylase | Często (30–79%) | W 1 chorobie |
| NDNnecdin, MAGE family member | Często (30–79%) | W 4 chorobach |
| NEFHneurofilament heavy chain | Często (30–79%) | W 1 chorobie |
| NEK1NIMA related kinase 1 | Często (30–79%) | W 1 chorobie |
| NF1neurofibromin 1 | Często (30–79%) | W 1 chorobie |
| NIPA1NIPA magnesium transporter 1 | Często (30–79%) | W 1 chorobie |
| NIPA2NIPA magnesium transporter 2 | Często (30–79%) | W 1 chorobie |
| NODALnodal growth differentiation factor | Często (30–79%) | W 4 chorobach |
| NOTCH2NLCnotch 2 N-terminal like C | Często (30–79%) | W 2 chorobach |
| NPAP1nuclear pore associated protein 1 | Często (30–79%) | W 1 chorobie |
| NPATnuclear protein, coactivator of histone transcription | Często (30–79%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Często (30–79%) | W 1 chorobie |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Często (30–79%) | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Często (30–79%) | W 2 chorobach |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Często (30–79%) | W 1 chorobie |
| OCA2OCA2 melanosomal transmembrane protein | Często (30–79%) | W 3 chorobach |
| OPTNoptineurin | Często (30–79%) | W 1 chorobie |
| PCDH19protocadherin 19 | Często (30–79%) | W 1 chorobie |
| PDPNpodoplanin | Często (30–79%) | W 1 chorobie |
| PEX1peroxisomal biogenesis factor 1 | Często (30–79%) | W 1 chorobie |
| PEX10peroxisomal biogenesis factor 10 | Często (30–79%) | W 1 chorobie |
| PEX11Bperoxisomal biogenesis factor 11 beta | Często (30–79%) | W 1 chorobie |
| PEX12peroxisomal biogenesis factor 12 | Często (30–79%) | W 1 chorobie |
| PEX13peroxisomal biogenesis factor 13 | Często (30–79%) | W 1 chorobie |
| PEX14peroxisomal biogenesis factor 14 | Często (30–79%) | W 1 chorobie |
| PEX16peroxisomal biogenesis factor 16 | Często (30–79%) | W 1 chorobie |
| PEX19peroxisomal biogenesis factor 19 | Często (30–79%) | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Często (30–79%) | W 1 chorobie |
| PEX26peroxisomal biogenesis factor 26 | Często (30–79%) | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Często (30–79%) | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Często (30–79%) | W 1 chorobie |
| PEX6peroxisomal biogenesis factor 6 | Często (30–79%) | W 1 chorobie |
| PFN1profilin 1 | Często (30–79%) | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PLCH1phospholipase C eta 1 | Często (30–79%) | W 1 chorobie |
| PMS1PMS1 homolog 1, mismatch repair system component | Często (30–79%) | W 1 chorobie |
| PMS2PMS1 homolog 2, mismatch repair system component | Często (30–79%) | W 1 chorobie |
| POLD1DNA polymerase delta 1, catalytic subunit | Często (30–79%) | W 1 chorobie |
| POLEDNA polymerase epsilon, catalytic subunit | Często (30–79%) | W 1 chorobie |
| POLGDNA polymerase gamma, catalytic subunit | Często (30–79%) | W 1 chorobie |
| PPOXprotoporphyrinogen oxidase | Często (30–79%) | W 1 chorobie |
| PRDM16PR/SET domain 16 | Często (30–79%) | W 1 chorobie |
| PRDM8PR/SET domain 8 | Często (30–79%) | W 1 chorobie |
| PRKCZprotein kinase C zeta | Często (30–79%) | W 1 chorobie |
| PRPHperipherin | Często (30–79%) | W 1 chorobie |
| PSMC3proteasome 26S subunit, ATPase 3 | Często (30–79%) | W 1 chorobie |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Często (30–79%) | W 1 chorobie |
| PTCH1patched 1 | Często (30–79%) | W 4 chorobach |
| PWAR1Prader Willi/Angelman region RNA 1 | Często (30–79%) | W 1 chorobie |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Często (30–79%) | W 1 chorobie |
| RAC1Rac family small GTPase 1 | Często (30–79%) | W 1 chorobie |
| RAI1retinoic acid induced 1 | Często (30–79%) | W 2 chorobach |
| REREarginine-glutamic acid dipeptide repeats | Często (30–79%) | W 2 chorobach |
| RHOBTB2Rho related BTB domain containing 2 | Często (30–79%) | W 1 chorobie |
| RPS20ribosomal protein S20 | Często (30–79%) | W 1 chorobie |
| SATB1SATB homeobox 1 | Często (30–79%) | W 1 chorobie |
| SATB2SATB homeobox 2 | Często (30–79%) | W 2 chorobach |
| SBDSSBDS ribosome maturation factor | Często (30–79%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Często (30–79%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Często (30–79%) | W 1 chorobie |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Często (30–79%) | W 2 chorobach |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Często (30–79%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Często (30–79%) | W 1 chorobie |
| SEMA4Asemaphorin 4A | Często (30–79%) | W 1 chorobie |
| SHHsonic hedgehog signaling molecule | Często (30–79%) | W 4 chorobach |
| SIM1SIM bHLH transcription factor 1 | Często (30–79%) | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Często (30–79%) | W 1 chorobie |
| SIX3SIX homeobox 3 | Często (30–79%) | W 4 chorobach |
| SKISKI proto-oncogene | Często (30–79%) | W 1 chorobie |
| SLC1A3solute carrier family 1 member 3 | Często (30–79%) | W 1 chorobie |
| SLC2A1solute carrier family 2 member 1 | Często (30–79%) | W 1 chorobie |
| SLC38A3solute carrier family 38 member 3 | Często (30–79%) | W 2 chorobach |
| SLC46A1solute carrier family 46 member 1 | Często (30–79%) | W 1 chorobie |
| SMARCA4SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | Często (30–79%) | W 1 chorobie |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Często (30–79%) | W 1 chorobie |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Często (30–79%) | W 1 chorobie |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Często (30–79%) | W 1 chorobie |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Często (30–79%) | W 1 chorobie |
| SMC1Astructural maintenance of chromosomes 1A | Często (30–79%) | W 1 chorobie |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Często (30–79%) | W 1 chorobie |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Często (30–79%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Często (30–79%) | W 6 chorobach |
| SOD1superoxide dismutase 1 | Często (30–79%) | W 1 chorobie |
| SOX11SRY-box transcription factor 11 | Często (30–79%) | W 1 chorobie |
| SOX4SRY-box transcription factor 4 | Często (30–79%) | W 1 chorobie |
| SPENspen family transcriptional repressor | Często (30–79%) | W 1 chorobie |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Często (30–79%) | W 2 chorobach |
| SPRsepiapterin reductase | Często (30–79%) | W 1 chorobie |
| SPRED1sprouty related EVH1 domain containing 1 | Często (30–79%) | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Często (30–79%) | W 1 chorobie |
| STAG2STAG2 cohesin complex component | Często (30–79%) | W 2 chorobach |
| STILSTIL centriolar assembly protein | Często (30–79%) | W 4 chorobach |
| STXBP1syntaxin binding protein 1 | Często (30–79%) | W 1 chorobie |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Często (30–79%) | W 2 chorobach |
| TAF15TATA-box binding protein associated factor 15 | Często (30–79%) | W 1 chorobie |
| TARDBPTAR DNA binding protein | Często (30–79%) | W 3 chorobach |
| TATtyrosine aminotransferase | Często (30–79%) | W 1 chorobie |
| TBK1TANK binding kinase 1 | Często (30–79%) | W 2 chorobach |
| TBPTATA-box binding protein | Często (30–79%) | W 1 chorobie |
| TGFBR2transforming growth factor beta receptor 2 | Często (30–79%) | W 1 chorobie |
| TGIF1TGFB induced factor homeobox 1 | Często (30–79%) | W 4 chorobach |
| THOC2THO complex subunit 2 | Często (30–79%) | W 2 chorobach |
| TIMM8Atranslocase of inner mitochondrial membrane 8A | Często (30–79%) | W 2 chorobach |
| TMEM138transmembrane protein 138 | Często (30–79%) | W 1 chorobie |
| TMEM216transmembrane protein 216 | Często (30–79%) | W 1 chorobie |
| TMEM231transmembrane protein 231 | Często (30–79%) | W 1 chorobie |
| TMEM237transmembrane protein 237 | Często (30–79%) | W 1 chorobie |
| TMEM240transmembrane protein 240 | Często (30–79%) | W 1 chorobie |
| TP53tumor protein p53 | Często (30–79%) | W 1 chorobie |
| TREX1three prime repair exonuclease 1 | Często (30–79%) | W 2 chorobach |
| TRIM32tripartite motif containing 32 | Często (30–79%) | W 1 chorobie |
| TRIOtrio Rho guanine nucleotide exchange factor | Często (30–79%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Często (30–79%) | W 1 chorobie |
| TTI2TELO2 interacting protein 2 | Często (30–79%) | W 1 chorobie |
| TUBG1tubulin gamma 1 | Często (30–79%) | W 1 chorobie |
| UBE4Bubiquitination factor E4B | Często (30–79%) | W 1 chorobie |
| UBQLN2ubiquilin 2 | Często (30–79%) | W 2 chorobach |
| UNC13Aunc-13 homolog A | Często (30–79%) | W 1 chorobie |
| USP48ubiquitin specific peptidase 48 | Często (30–79%) | W 1 chorobie |
| USP8ubiquitin specific peptidase 8 | Często (30–79%) | W 1 chorobie |
| VAMP2vesicle associated membrane protein 2 | Często (30–79%) | W 1 chorobie |
| VAPBVAMP associated protein B and C | Często (30–79%) | W 1 chorobie |
| VPS13Avacuolar protein sorting 13 homolog A | Często (30–79%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Często (30–79%) | W 1 chorobie |
| YY1YY1 transcription factor | Często (30–79%) | W 2 chorobach |
| ZIC2Zic family zinc finger 2 | Często (30–79%) | W 4 chorobach |
| ZMYM3zinc finger MYM-type containing 3 | Często (30–79%) | W 1 chorobie |
| ZNF423zinc finger protein 423 | Często (30–79%) | W 1 chorobie |
| AARS1alanyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| ACADSacyl-CoA dehydrogenase short chain | Czasami (5–29%) | W 1 chorobie |
| ACSF3acyl-CoA synthetase family member 3 | Czasami (5–29%) | W 1 chorobie |
| ACTL6Bactin like 6B | Czasami (5–29%) | W 1 chorobie |
| AGAaspartylglucosaminidase | Czasami (5–29%) | W 1 chorobie |
| ALKALK receptor tyrosine kinase | Czasami (5–29%) | W 1 chorobie |
| ALS2alsin Rho guanine nucleotide exchange factor ALS2 | Czasami (5–29%) | W 1 chorobie |
| AP3B2adaptor related protein complex 3 subunit beta 2 | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ARXaristaless related homeobox | Czasami (5–29%) | W 1 chorobie |
| ATP10AATPase phospholipid transporting 10A (putative) | Czasami (5–29%) | W 1 chorobie |
| ATP13A2ATPase cation transporting 13A2 | Czasami (5–29%) | W 1 chorobie |
| ATP6V1AATPase H+ transporting V1 subunit A | Czasami (5–29%) | W 1 chorobie |
| C4Acomplement C4A (Chido/Rodgers blood group) | Czasami (5–29%) | W 1 chorobie |
| CACNA1Bcalcium voltage-gated channel subunit alpha1 B | Czasami (5–29%) | W 1 chorobie |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Czasami (5–29%) | W 1 chorobie |
| CBScystathionine beta-synthase | Czasami (5–29%) | W 2 chorobach |
| CCR1C-C motif chemokine receptor 1 | Czasami (5–29%) | W 1 chorobie |
| CDK19cyclin dependent kinase 19 | Czasami (5–29%) | W 1 chorobie |
| CELF2CUGBP Elav-like family member 2 | Czasami (5–29%) | W 1 chorobie |
| CISD2CDGSH iron sulfur domain 2 | Czasami (5–29%) | W 1 chorobie |
| CLN8CLN8 transmembrane ER and ERGIC protein | Czasami (5–29%) | W 1 chorobie |
| CLTCclathrin heavy chain | Czasami (5–29%) | W 1 chorobie |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Czasami (5–29%) | W 1 chorobie |
| CNTNAP2contactin associated protein 2 | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CST3cystatin C | Czasami (5–29%) | W 1 chorobie |
| CYFIP2cytoplasmic FMR1 interacting protein 2 | Czasami (5–29%) | W 1 chorobie |
| DALRD3DALR anticodon binding domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| DDX3XDEAD-box helicase 3 X-linked | Czasami (5–29%) | W 1 chorobie |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Czasami (5–29%) | W 3 chorobach |
| DHDDSdehydrodolichyl diphosphate synthase subunit | Czasami (5–29%) | W 1 chorobie |
| DIP2BDIP2 acetate--CoA ligase B (putative) | Czasami (5–29%) | W 1 chorobie |
| DLDdihydrolipoamide dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| EEF1A2eukaryotic translation elongation factor 1 alpha 2 | Czasami (5–29%) | W 1 chorobie |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Czasami (5–29%) | W 1 chorobie |
| ERLIN1ER lipid raft associated 1 | Czasami (5–29%) | W 1 chorobie |
| FASFas cell surface death receptor | Czasami (5–29%) | W 1 chorobie |
| FBXO28F-box protein 28 | Czasami (5–29%) | W 1 chorobie |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| FGF12fibroblast growth factor 12 | Czasami (5–29%) | W 1 chorobie |
| FLT4fms related receptor tyrosine kinase 4 | Czasami (5–29%) | W 1 chorobie |
| FOXG1forkhead box G1 | Czasami (5–29%) | W 1 chorobie |
| FZR1fizzy and cell division cycle 20 related 1 | Czasami (5–29%) | W 1 chorobie |
| GABBR2gamma-aminobutyric acid type B receptor subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GABRA2gamma-aminobutyric acid type A receptor subunit alpha2 | Czasami (5–29%) | W 1 chorobie |
| GABRA5gamma-aminobutyric acid type A receptor subunit alpha5 | Czasami (5–29%) | W 1 chorobie |
| GABRB2gamma-aminobutyric acid type A receptor subunit beta2 | Czasami (5–29%) | W 1 chorobie |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Czasami (5–29%) | W 1 chorobie |
| GATMglycine amidinotransferase | Czasami (5–29%) | W 1 chorobie |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| GPC4glypican 4 | Czasami (5–29%) | W 1 chorobie |
| GRIN2Dglutamate ionotropic receptor NMDA type subunit 2D | Czasami (5–29%) | W 1 chorobie |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Czasami (5–29%) | W 1 chorobie |
| HCRThypocretin neuropeptide precursor | Czasami (5–29%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HLA-Bmajor histocompatibility complex, class I, B | Czasami (5–29%) | W 1 chorobie |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Czasami (5–29%) | W 1 chorobie |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Czasami (5–29%) | W 1 chorobie |
| HNRNPA2B1heterogeneous nuclear ribonucleoprotein A2/B1 | Czasami (5–29%) | W 1 chorobie |
| IFNGR1interferon gamma receptor 1 | Czasami (5–29%) | W 1 chorobie |
| IL10interleukin 10 | Czasami (5–29%) | W 1 chorobie |
| IL12Ainterleukin 12A | Czasami (5–29%) | W 1 chorobie |
| IL12A-AS1IL12A antisense RNA 1 | Czasami (5–29%) | W 1 chorobie |
| IL23Rinterleukin 23 receptor | Czasami (5–29%) | W 1 chorobie |
| IRF6interferon regulatory factor 6 | Czasami (5–29%) | W 1 chorobie |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| JPH3junctophilin 3 | Czasami (5–29%) | W 1 chorobie |
| KCNA2potassium voltage-gated channel subfamily A member 2 | Czasami (5–29%) | W 1 chorobie |
| KCNB1potassium voltage-gated channel subfamily B member 1 | Czasami (5–29%) | W 1 chorobie |
| KCNC2potassium voltage-gated channel subfamily C member 2 | Czasami (5–29%) | W 1 chorobie |
| KCNH5potassium voltage-gated channel subfamily H member 5 | Czasami (5–29%) | W 1 chorobie |
| KLRC4killer cell lectin like receptor C4 | Czasami (5–29%) | W 1 chorobie |
| LAMP2lysosome associated membrane protein 2 | Czasami (5–29%) | W 1 chorobie |
| LHCGRluteinizing hormone/choriogonadotropin receptor | Czasami (5–29%) | W 1 chorobie |
| LRP1LDL receptor related protein 1 | Czasami (5–29%) | W 1 chorobie |
| MAN1B1mannosidase alpha class 1B member 1 | Czasami (5–29%) | W 1 chorobie |
| MAN2B1mannosidase alpha class 2B member 1 | Czasami (5–29%) | W 2 chorobach |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Czasami (5–29%) | W 1 chorobie |
| MEFVMEFV innate immunity regulator, pyrin | Czasami (5–29%) | W 1 chorobie |
| MIR17HGmiR-17-92a-1 cluster host gene | Czasami (5–29%) | W 1 chorobie |
| MMACHCmetabolism of cobalamin associated C | Czasami (5–29%) | W 1 chorobie |
| MSX1msh homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| MTRR5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Czasami (5–29%) | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| NAXDNAD(P)HX dehydratase | Czasami (5–29%) | W 1 chorobie |
| NAXENAD(P)HX epimerase | Czasami (5–29%) | W 1 chorobie |
| NDPnorrin cystine knot growth factor NDP | Czasami (5–29%) | W 1 chorobie |
| NECAP1NECAP endocytosis associated 1 | Czasami (5–29%) | W 1 chorobie |
| NECTIN1nectin cell adhesion molecule 1 | Czasami (5–29%) | W 1 chorobie |
| NHSNHS actin remodeling regulator | Czasami (5–29%) | W 1 chorobie |
| NPRL2NPR2 like, GATOR1 complex subunit | Czasami (5–29%) | W 1 chorobie |
| NPRL3NPR3 like, GATOR1 complex subunit | Czasami (5–29%) | W 1 chorobie |
| NRASNRAS proto-oncogene, GTPase | Czasami (5–29%) | W 1 chorobie |
| NTRK2neurotrophic receptor tyrosine kinase 2 | Czasami (5–29%) | W 1 chorobie |
| NUS1NUS1 dehydrodolichyl diphosphate synthase subunit | Czasami (5–29%) | W 1 chorobie |
| ODC1ornithine decarboxylase 1 | Czasami (5–29%) | W 1 chorobie |
| PACS2phosphofurin acidic cluster sorting protein 2 | Czasami (5–29%) | W 1 chorobie |
| PARS2prolyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| PDE11Aphosphodiesterase 11A | Czasami (5–29%) | W 1 chorobie |
| PHGDHphosphoglycerate dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| PLA2G6phospholipase A2 group VI | Czasami (5–29%) | W 1 chorobie |
| PNPpurine nucleoside phosphorylase | Czasami (5–29%) | W 2 chorobach |
| PNPLA6patatin like domain 6, lysophospholipase | Czasami (5–29%) | W 1 chorobie |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Czasami (5–29%) | W 1 chorobie |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Czasami (5–29%) | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Czasami (5–29%) | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Czasami (5–29%) | W 1 chorobie |
| RNF216ring finger protein 216 | Czasami (5–29%) | W 1 chorobie |
| RPS6KA3ribosomal protein S6 kinase A3 | Czasami (5–29%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SACSsacsin molecular chaperone | Czasami (5–29%) | W 1 chorobie |
| SCN3Asodium voltage-gated channel alpha subunit 3 | Czasami (5–29%) | W 2 chorobach |
| SCN8Asodium voltage-gated channel alpha subunit 8 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SIGMAR1sigma receptor chaperone 1 | Czasami (5–29%) | W 1 chorobie |
| SLC13A5solute carrier family 13 member 5 | Czasami (5–29%) | W 1 chorobie |
| SLC1A2solute carrier family 1 member 2 | Czasami (5–29%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Czasami (5–29%) | W 1 chorobie |
| SORDsorbitol dehydrogenase | Czasami (5–29%) | W 1 chorobie |
| SOX5SRY-box transcription factor 5 | Czasami (5–29%) | W 1 chorobie |
| SPTBN1spectrin beta, non-erythrocytic 1 | Czasami (5–29%) | W 1 chorobie |
| SPTLC1serine palmitoyltransferase long chain base subunit 1 | Czasami (5–29%) | W 1 chorobie |
| SPTLC2serine palmitoyltransferase long chain base subunit 2 | Czasami (5–29%) | W 1 chorobie |
| STAT4signal transducer and activator of transcription 4 | Czasami (5–29%) | W 1 chorobie |
| SYNE1spectrin repeat containing nuclear envelope protein 1 | Czasami (5–29%) | W 1 chorobie |
| SYNJ1synaptojanin 1 | Czasami (5–29%) | W 1 chorobie |
| SZT2SZT2 subunit of KICSTOR complex | Czasami (5–29%) | W 1 chorobie |
| TAF11TATA-box binding protein associated factor 11 | Czasami (5–29%) | W 1 chorobie |
| TBX1T-box transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| TBX4T-box transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| TLR4toll like receptor 4 | Czasami (5–29%) | W 1 chorobie |
| TNFRSF1ATNF receptor superfamily member 1A | Czasami (5–29%) | W 1 chorobie |
| TP63tumor protein p63 | Czasami (5–29%) | W 1 chorobie |
| TRAK1trafficking kinesin protein 1 | Czasami (5–29%) | W 1 chorobie |
| TRMT2BtRNA methyltransferase 2B | Czasami (5–29%) | W 1 chorobie |
| UBA5ubiquitin like modifier activating enzyme 5 | Czasami (5–29%) | W 1 chorobie |
| UBAC2UBA domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| UBE3Aubiquitin protein ligase E3A | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| UFSP2UFM1 specific peptidase 2 | Czasami (5–29%) | W 1 chorobie |
| WFS1wolframin ER transmembrane glycoprotein | Czasami (5–29%) | W 2 chorobach |
| YWHAGtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | Czasami (5–29%) | W 1 chorobie |
| ZEB2zinc finger E-box binding homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| ZFYVE26zinc finger FYVE-type containing 26 | Czasami (5–29%) | W 1 chorobie |
| ZNF365zinc finger protein 365 | Czasami (5–29%) | W 1 chorobie |
| AFG3L2AFG3 like matrix AAA peptidase subunit 2 | Rzadko (1–4%) | W 1 chorobie |
| CABP4calcium binding protein 4 | Rzadko (1–4%) | W 1 chorobie |
| CHRNA2cholinergic receptor nicotinic alpha 2 subunit | Rzadko (1–4%) | W 2 chorobach |
| CHRNA4cholinergic receptor nicotinic alpha 4 subunit | Rzadko (1–4%) | W 1 chorobie |
| CHRNB2cholinergic receptor nicotinic beta 2 subunit | Rzadko (1–4%) | W 1 chorobie |
| CRHcorticotropin releasing hormone | Rzadko (1–4%) | W 1 chorobie |
| ELOVL5ELOVL fatty acid elongase 5 | Rzadko (1–4%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Rzadko (1–4%) | W 1 chorobie |
| GJA8gap junction protein alpha 8 | Rzadko (1–4%) | W 1 chorobie |
| HALhistidine ammonia-lyase | Rzadko (1–4%) | W 1 chorobie |
| LGI1leucine rich glioma inactivated 1 | Rzadko (1–4%) | W 1 chorobie |
| LMNB1lamin B1 | Rzadko (1–4%) | W 1 chorobie |
| MICAL1microtubule associated monooxygenase, calponin and LIM domain containing 1 | Rzadko (1–4%) | W 1 chorobie |
| NAGSN-acetylglutamate synthase | Rzadko (1–4%) | W 1 chorobie |
| RELNreelin | Rzadko (1–4%) | W 1 chorobie |
| RORBRAR related orphan receptor B | Rzadko (1–4%) | W 1 chorobie |
| SMPD1sphingomyelin phosphodiesterase 1 | Rzadko (1–4%) | W 1 chorobie |
| BLTP1bridge-like lipid transfer protein family member 1 | Nie odnotowano | W 1 chorobie |
| CDC42cell division cycle 42 | Nie odnotowano | W 1 chorobie |
| CSF1Rcolony stimulating factor 1 receptor | Nie odnotowano | W 1 chorobie |
| CYLDCYLD lysine 63 deubiquitinase | Nie odnotowano | W 1 chorobie |
| EML1EMAP like 1 | Nie odnotowano | W 1 chorobie |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Nie odnotowano | W 1 chorobie |
| HDAC8histone deacetylase 8 | Nie odnotowano | W 1 chorobie |
| KDM6Alysine demethylase 6A | Nie odnotowano | W 1 chorobie |
| NOTCH3notch receptor 3 | Nie odnotowano | W 1 chorobie |
| RLIMring finger protein, LIM domain interacting | Nie odnotowano | W 1 chorobie |
| SLC45A1solute carrier family 45 member 1 | Nie odnotowano | W 1 chorobie |
| USP27Xubiquitin specific peptidase 27 X-linked | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
- Abnormal social behavior44 genów
- Impaired executive functioning16 genów
- Shyness12 genów
- Inappropriate sexual behavior3 genów
- Pseudobulbar affect3 genów
- Reduced impulse control2 genów
- Non-epileptic seizure1 gen
- Abnormal demeanor
- Abnormal play
- Abnormal relationship
- Diagnostic behavioral phenotype
- Echophenomenon
- Impairment in personality functioning
- Recurrent maladaptive behavior
- Sensory behavioral abnormality
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni